TY - JOUR
T1 - NCCN Guidelines Updates
T2 - Management of Prostate Cancer
AU - Mohler, James L.
AU - Antonarakis, Emmanuel S.
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Updates to the NCCN Guidelines for Prostate Cancer include further refinements in taking a family history, new recommendations for germline and somatic testing, use of androgen receptor blockers for nonmetastatic castration-resistant prostate cancer, advice regarding intermittent versus continuous androgen deprivation therapy, and consideration of whether to treat the primary tumor in men diagnosed with de novo metastatic prostate cancer.
AB - Updates to the NCCN Guidelines for Prostate Cancer include further refinements in taking a family history, new recommendations for germline and somatic testing, use of androgen receptor blockers for nonmetastatic castration-resistant prostate cancer, advice regarding intermittent versus continuous androgen deprivation therapy, and consideration of whether to treat the primary tumor in men diagnosed with de novo metastatic prostate cancer.
UR - http://www.scopus.com/inward/record.url?scp=85066486130&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066486130&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2019.5011
DO - 10.6004/jnccn.2019.5011
M3 - Letter
C2 - 31117038
AN - SCOPUS:85066486130
SN - 1540-1405
VL - 17
SP - 583
EP - 586
JO - Journal of the National Comprehensive Cancer Network : JNCCN
JF - Journal of the National Comprehensive Cancer Network : JNCCN
IS - 55
ER -
